Nabsys

Electronic Genome Mapping Setting a new standard in structural variant analysis Nabsys, the pioneer of electronic genome mapping (EGM), uses solid-state nanodetectors to survey long DNA molecules to construct high-density maps with long-range information required to detect structural variants (SVs). Unlike other DNA mapping technologies that rely on the use of expensive optical imaging or fluorescent labels whose resolution is inherently limited by light diffraction, EGM identifies tags in close proximity therebye producing superior resolution. This high-density information makes it possible to identify both balanced and unbalanced SVs as small as 300 bp, in addition to larger chromosomal aberrations and...

Solid-state nanodetectors,electronic detection,biochemistry,genome mapping,genome assembly,structural variation,strain identification,de novo assembly,assembly scaffolding,metagenomics,microbiome,pathogen identification,sv validation,and sv discovery

Nabsys operates in the Biotechnology research industry.

Nabsys's revenue is 11m - 100m

Nabsys has 51 - 200 employees.